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ELgin 3311 
ELgin 2176
Dr. Alexander D. Langmuir 
Chief, Epidemiology Branch
Home phone - CRescent 9207
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Chief Poliomyelitis Surveillance
Home phone - CHerokee 7520
Mr. Earl Diamond Home phone - ATwood 2791
Statistician, Poliomyelitis Surveillance
Dr. Ira L. Myers Home phone - DEarborn 0482
Assistant to the Chief
SPECIAL NOTE
The information provided in this report represents the latest data 
reported to the Poliomyelitis Surveillance Unit from State Health Departments, 
Epidemic Intelligence Service Officers, participating laboratories, and other 
pertinent sources. Much of the material is preliminary in nature and is sub­
ject to confirmation and change. It is distributed for the benefit of all 
participants with the understanding that it will not be released to the press 
or to unauthorized persons. State Health Officers, of course, are free to 
reveal any information they may wish concerning data from their State.
The recent occurrence of cases of poliomyelitis among children who 
had recently been inoculated with poliomyelitis vaccine manufactured by 
Cutter Laboratories dramatically illustrated the need for establishing a 
nationwide system of collecting accurate and detailed reports on all cases 
°f poliomyelitis in the country. It was imperative to determine as rapidly 
as possible the nature of the apparent association of cases with Cutter 
Vaccine.
Similar associations with vaccines from other manufacturers might 
occur at any time. As increasing numbers of children become immunized and 
as the normal poliomyelitis season approaches, it may be expected by mere 
coincidence that many children will contract poliomyelitis at some time follow­
ing vaccination. In order to interpret such occurrences properly, it is neces- 
s&ry that accurate current information be available on a national basis in far 
tfiore detail and more rapidly than is now available through established mor­
bidity reporting channels.
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Accordingly, on April 28, one day following the discovery of the 
association of cases of poliomyelitis with Cutter Vaccine and its with­
drawal from use, the Surgeon General of the Public Health Service directed 
the establishment of the Poliomyelitis Surveillance Unit within the Com­
municable Disease Center in Atlanta. The two documents establishing this 
Unit are attached: l) The news release of April 28, 1955, and 2) the tele­
gram to all Regional Medical Directors of the Public Health Service from 
Otis L. Anderson, Chief, Bureau of State Services of the Public Health 
Service.
The Surveillance Program will serve broad functions. The accurate 
and detailed information collected and disseminated currently to Federal 
and State Health Officials and participating laboratories should serve to 
guide the most effective application of the limited supplies of vaccine 
available in 1955. The wise use of these supplies should accelerate the 
decline of poliomyelitis throughout the country, leading, it may be hoped, 
to rapid disappearance of the disease.
With the decline in incidence of poliomyelitis, the many types of 
disease that may simulate poliomyelitis will assume increasing relative 
importance to the public, to physicians, and to health officers. In many 
instances, diseases such as arthropod-borne viral encephalitis, and other 
types of encephalitis, or Coxsackie virus infections or leptospirosis, or 
many types of meningitis may well be diagnosed as poliomyelitis. Unless 
such a diagnosis is promptly corrected, much public concern is likely to 
be felt. Unnecessary loss in confidence in the poliomyelitis vaccine might 
develop. A National Surveillance Program for poliomyelitis shall bring to 
the attention of all health officers the existence of these types of disease
and should serve to achieve prompter and more correct diagnoses when they
occur. Expanded laboratory services will be needed to make these correct 
diagnoses.
Included with this first Poliomyelitis Surveillance Report is a 
Cumulative summary of the accepted cases of poliomyelitis associated with 
the prior administration of vaccine that have been reported up to 2:00 P.M. 
Sunday, May 1st. A total of 22 paralytic cases and one non-paralytic case 
have been associated with prior inoculation of Cutter Vaccine of several 
different lot numbers. In many instances it has not been possible specific­
ally to identify the lot a particular patient had received.
In a high proportion of cases there is a marked correlation between
the site of inoculation and the site of first paralysis. The intervals be­
tween inoculation and date of first paralysis have varied from 6 to 13 days 
with the majority falling between 8 and 10 days. Most of the cases have 
shown a short prodromal period of symptoms prior to recognized paralysis.
The cases have been concentrated largely in California 15 cases, and 
Idaho 6, with single cases in Colorado and Illinois. Additional suspect 








Further information concerning the relation of the occurrence of 
these cases to the distribution of Cutter Vaccine will be presented in 
future reports when more basic data are available.
A total of 3 cases, two paralytic and one non-paralytic, have occurred 
in association with Lilly Vaccine. One of these was in Georgia and two in 
Louisiana. A correlation between site of inoculation and site of first 
paralysis was not observed in any of these cases.
Etiological studies of these cases are now being undertaken in the 
following laboratories:
1. Virus and Rickettsial Laboratory 
California Department of Public Health 
Berkeley, California
Dr. Edwin H. Lennette, Director
2. Rocky Mountain Laboratory 
National Institutes of Health 
Hamilton, Montana
Dr. Carl Larson, Director
Dr. Karl Eklund, Virologist
3. Division of Laboratories
Illinois Department of Public Health
Dr. Howard Shaughnessey, Director
4. School of Medicine
Tulane University, New Orleans, La.
Dr. John P. Fox
5. Virus and Rickettsial Laboratory 
Communicable Disease Center, PHS 
Montgomery, Alabama
Dr. Morris Schaeffer, Chief
As additional cases of poliomyelitis are reported either among vac­
cinated or non-vaccinated persons, it is hoped that immediate etiological 
studies will be initiated. When laboratory services cannot be arranged in 
the area of the cases, the Montgomery Laboratory of CDC stands ready within 
the limits of its capacity to assist.
Further data regarding laboratory findings and recommended procedures 
for submission of specimens to laboratories will be sent with future reports.
A brief daily report of new cases and corrections of the data presented 
in the emulative summary will be sent to all participants. (See attached 
list). A weekly summary will also be a regular feature of the program.
t ] • • v-V •n-v—
Alexander D. Langmuir, M. D. 
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Cal-1 San Diego LV 7 M U- 1 6 U—20 h-23 LA LA C E6G38?
E5970
E9928?
Cal-2 San Diego JMcD 7 M U-l6 h-22 h-2h LA LA C II
Cal-3 San Diego EC 8 F U- 1 6 h-25 h-27 LA LA c II
Cal-U Ventura MD 1 M li-l6 h-21 U-25 LA LA c E5971
Cal-5 Napa GK 1 F U- 1 6 h-21 h-2h LA LA c E6oU5?
E$97U?
Cal-6 Oakland RF h M U-18 h-2h h-2.6 LA LA c E6oIi5
Cal-7 Oakland JB 3 F h -lh h-21 h-27 ? RL c e 6o!j5
Cal-8 Los Angeles MB 5 F h-19 h-2k 7 ? LA c E9971
Cal-9 Los Angeles 
County RN 1 M h-19 ii-25 ? ? 7 c E5972 Quadriplegia
Cal-10 Los Angeles 











Cal-11 Riverside DM 8 F ii- 1 8 U-23 U- 2 6
Cal-12 Stanislaw
County CS 2 F U—17 U-23 U—27
Cal-13 San Diego DS 7 F U—1 6 U-23 ?
Cal-ll; San Diego JMcC 6 F ii-l6 U-22 None
Cal-15 Santa Barbara AG U F U-18 U-23 U—28
Colorado
Colo-1 Denver SC 1 M U-i5 U-21 U-2U
Georgia
Ga-1 Columbus r\ 0 M U-19 U-23 U-27
Idaho
lda-1 Pocatello SP 7 F U—18 U-23 U-2U
Ida-2 Pocatello JS 6 M U—20 U- 2 6  U-27
Ida-3 Orof inc DC 8 F U-21 U- 2 6  U-27
Ida-i| Lewiston BP 7 F U-19 U - 2U u - 2 7








RL RL C E5972
LA 9 C E6 0J45
LA LA C E6 0 3 8 ?
E5970
E5928?
LA None C f
RL RL C E5971
LA ? C E5972 Quadriplegia
RA ? L 5 0 8 1 Mild bulbar




LA LA C E6039?
E6o58?
RA RA C E6o58
LA LA C E6o58














Ida-6 Moscow CS 7 F U—20 U- 2 8 ii-2 9
Illinois
111-1 Chicago 9 1 M U- 1 6 ? h-29
Louisiana
La-1 Winnsboro ?B 6 M h-19 U—19 ii-28
La-2 Monroe ?S 6 F U-21 U—22 None
Code of Abbreviations:
PSU - Poliomyelitis Surveillance Unit 
Mfr - Manufacturer 
C - Cutter Laboratories 
L - Lilly Laboratories 
LA - Left Arm LL - Left Leg or Buttocks








LA LA C E6058
Leg ? C E6oUi Paraplegia
LA Legs L 5 0 8 1
Arm None L 5 0 8 1

May 1, 1955
Attachment No. 1 to
Poliomyelitis Surveillance Report No. 1
The following press release was issued by the Surgeon General of the 
Public Health Service at 7 PM Thursday, April 28, 1955*
"THE PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE, 
ANNOUNCED TODAY THAT IT HAS ESTABLISHED AN INTENSIVE NETWORK FOR REPORTING ON 
EACH CASE OF POLIO THAT OCCURS THIS YEAR.
"THE SERVICE STATED THAT THIS STEP WAS IN ADDITION TO THE MEASURES AL­
READY TAKEN TO CLARIFY THE STATUS OF THE POLIOMYELITIS VACCINE MANUFACTURED '
BY THE CUTTER LABORATORIES IN BERKELEY, CALIFORNIA.
"THE GROUP OF PHYSICIANS, STATISTICIANS, AND OTHER SPECIALISTS IN IDENTI- 
IYING, REPORTING AND INTERPRETING THE OCCURRENCE OF INFECTIOUS DISEASE AMONG 
LARGE POPULATION GROUPS HAS ITS HEADQUARTERS AT THE SERVICE’S COMMUNICABLE 
DISEASE CENTER IN ATLANTA, GEORGIA. THE GROUP, WHICH IS UNDER THE IMMEDIATE 
DIRECTION OF DR. ALEXANDER LANGMUIR, ASSISTS STATES TO TRACK D O W  OUTBREAKS OF 
COMMUNICABLE DISEASES.
"THE GROUP WILL WORK WITH STATE MEDICAL AND PUBLIC HEALTH AUTHORITIES, 
WITH EMPHASIS ON CONFIRMATION OF REPORTED CASES, DATA ON WHETHER THE CASE HAS 
BEEN VACCINATED THIS YEAR OR LAST, LABORATORY CONFIRMATION OF DIAGNOSIS, AND 
CORRELATION OF DATA TO PROVIDE A DAILY RECORD. WEEKLY SUMMARIES OF POLIOMYE­
LITIS PICTURE WILL BE ISSUED THROUGHOUT THE SUMMER.
"THIS EPIDEMIOLOGICAL STUDY WILL YIELD DATA ON THE CURRENT URGE-SCALE 
IMMUNICATION PROGRAM AND WILL BE VERY USEFUL TO THE CONTINUING EVALUATION OF 
THE PROGRAM ON A STATE AND LOCAL LEVEL, THE SERVICE SAID.
"THE LANGMUIR GROUP IS NOW PROVIDING SPECIAL ASSISTANCE TO THE STATE OF 
CALIFORNIA, WHERE MOST OF THE REPORTED CASES OF POLIOMYELITIS HAVE OCCURRED.
"IN MAKING THIS ANNOUNCEMENT, THE SURGEON GENERAL OF THE PUBLIC HEALTH 
SERVICE, DR. LEONARD A. SCHEELE, REITERATED HIS STATEMENT OF YESTERDAY THAT 
THE WITHDRAWAL OF CUTTER VACCINE FROM DISTRIBUTION DOES NOT IMPLY THAT THERE 
IS ANY CORRELATION BETWEEN THE VACCINE AND THE OCCURRENCE OF POLIOMYELITIS.
"THERE HAVE BEEN ONLY THREE NEW CASES OF POLIOMYELITIS REPORTED AMONG 
VACCINATED CHILDREN IN THE LAST TWENTY-FOUR HOURS, ’ HE SAID. ’IT CANNOT EE
expected that vac c i n e would p rovide protection so so o n af t e r a first inj e c t i o n.
ACCORDING TO THE STUDY OF DR. FRANCIS, MOREOVER, THE SALK VACCINE IS 60-90 
PERCENT EFFECTIVE AFTER FULL IMMUNIZATION. THUS IN ANY URGE GROUP OF CHILD­
REN WHO HAVE RECEIVED THE FULL COURSE OF IMMUNIZATION, IT CAN PE EXPECTED THAT 
THERE WILL BE SOME WHO WILL CONTACT THE DISUSE.
"’THERE IS NOTHING UNUSUAL ABOUT THE POLIO PICTURE ACROSS THE NATION,’
HE ADDED. ’IT FOLLOWS VERY CLOSE TO THE FIVE YEAR MEDIAN.’"
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Attachment No. 2 to 
Poliomyelitis Surveillance Report No. 1
The following telegram was sent night letter to each Regional Medical 
Director of the Public Health Service on April 30, 1955*
’’THE SURGEON GENERAL HAS REQUESTED YOU TO NOTIFY BY TELEPHONE ALL STATE 
AND TERRITORIAL HEALTH OFFICERS IN YOUR REGION OF ESTABLISHMENT POLIOMYELITIS 
SURVEILLANCE UNIT IN THE COMMUNICABLE DISEASE CENTER ATLANTA. THIS UNIT IS 
DIRECTED BY DR. A D LANGMUIR WITH DR. NEAL NATHANSON EPIDEMIC INTELLIGENCE 
SERVICE PHYSICIAN AND MR. EARL DIAMOND EIS STATISTICIAN AS CENTRAL STAFF FULL 
RESOURCES EPIDEMIOLOGY BRANCH INCLUDING EIS OFFICERS ARE ASSIGNED FOR FIRST 
PRIORITY DUTY TO SERVE AT REQUEST OF STATE TO HELP WHERE NEEDED TO INVESTIGATE 
ALL CASES OF POLIOMYELITIS THIS YEAR PLAN NATION WIDE COVERAGE.
"COMMITTEE OF POLIOMYELITIS EXPERTS AND IMMUNOLOGISTS MEETING IN WASH­
INGTON APRIL 29 AND 30 STRESS URGENCY OF DETAILED STUDIES TO DETERMINE THROUGH­
OUT VACCINATION PERIOD WHICH OF THREE EXPLANATIONS IS APPLICABLE TO CASES. 
FIRST: IS CURRENT POLIOMYELITIS IN VACCINATED INDIVIDUALS PURE COINCIDENCE? 
SECOND: HAS INJECTION PROVOKED PARALYSIS AS HAS BEEN OBSERVED AFTER USE OF 
OTHER VACCINE? THIRD: WAS A LIVE VIRUS INTRODUCED BY INFECTED VACCINE?
"BASIC OPERATION OF PROGRAM IS ESTABLISHMENTS NATIONAL REGISTRY OF DE­
TAILED INFORMATION ALL POLIOMYELITIS CASES FROM APRIL 12 1955 UNTIL FURTHER 
NOTICE. MINIMUM ESSENTIAL DATA ON EACH CASE ARE: PATIENTS INITIALS AGE SEX 
RESIDENCE DATE ONSET SYMPTOMS DATE AND SITE FIRST PARALYSIS EXTENT OF PARALY­
SIS HISTORY OF INNOCULATION POLIO VACCINE WITH DATE LOT NO. MANUFACTURER AND 
SITE OF INNOCULATION. SPECIAL FORM FOR THIS INFORMATION AVAILABLE TO ALL EIS 
OFFICERS AND TO THE STATES UPON REQUEST. URGE IMMEDIATE PRELIMINARY REPORTS 
FROM STATES ON ALL NEW CASES WITH SUPPLEMENTAL REPORTS TO COMPLETE THE MINI­
MUM ESSENTIAL DATA WHEN IT BECOMES AVAILABLE.
"REPORTS SHOULD BE SENT AT LEAST DAILY DIRECTLY TO SURVEILLANCE UNIT 
IN ATLANTA BY GOVERNMENT TELETYPE TELEGRAPH OR TELEPHONE COLLECT. IMMEDIATE 
REPORTS OF SIGNIFICANT CASES MOST IMPORTANT. TELEPHONE NOS. DAYTIME BAM TO 
530PM EST ELGIN 3311, 530PM TO 10PM ELGIN 2176.
"EVERY CASE OF POLIOMYELITIS SHOULD HAVE LABORATORY CONFIRMATION IF 
POSSIBLE BY ATTEMPTED VIRUS ISOLATION FROM FECES WITH TYPING. ACCUTE AND 
CONVALESCENT SERA SHOULD ALSO BE COLLECTED FOR APPROPRIATE SEROLOGY. MONTGOMERY
laboratory o f cdc a v ailable t o se r v e all states o r territories but recommend 
utilization o f laboratories in t h e area w h e n prepared to do isolation and 
typing v i r u s, isolation f r o m household contacts also important, regular
WEEKLY REPORTS OF COMMUNICABLE DISEASES INCLUDING POLIOMYELITIS SHOULD CON­
TINUE WITHOUT CHANGE THROUGH REGULAR CHANNELS TO NATIONAL OFFICE OF VITAL 
STATISTICS. URGE PROMPTEST AND FULLEST PARTICIPATION ALL STATES AND TERRI­
TORIES IN THIS PROGRAM. REQUEST EACH STATE HEALTH OFFICER TO DESIGNATE A 
POLIOMYELITIS REPORTING OFFICER TO SERVE AS CONTACT POINT FOR CONTINUING DIRECT
Communication between surveillance unit and each st a t e as so o n as y o u learn who 
This INDIVIDUAL IS NOTIFY CHIEF CDC.
- 2 -
"ANTICIPATE THAT DAILY REPORTS WILL BE SENT FROM THE SURVEILLANCE 
UNITS TO ALL AUTHORIZED PERSONS INCLUDING STATE HEALTH OFFICERS WITH THE 
STRICT UNDERSTANDING NONE OF REPORTED INFORMATION CAN BE RELEASED TO THE 
PUBLIC EXCEPT THROUGH OFFICE OF THE SURGEON GENERAL IN WASHINGTON. THIS 
LIMITATION NECESSARY BECAUSE MUCH INFORMATION WILL BE PRELIMINARY AND 
SUBJECT TO MODIFICATION AND CHANGE RESULTING FROM FIELD INVESTIGATION AT 
MOST ONLY NUMBERS OF CASES PLACES OF OCCURRENCE AND MANUFACTURERS NAME 
WOULD BE RELEASED BY THE SURGEON GENERAL. THIS LIMITATION DOES NOT PRE­
CLUDE RELEASES BY STATE HEALTH OFFICER OF FULL DATA FOR HIS STATE. EXPECT 
FIRST REPORT WILL BE MAILED SUNDAY NIGHT MAY FIRST. MORE DETAILED INFOR­
MATION ON PLANS AND ORGANIZATION WILL BE FORWARDED SHORTLY."
OTIS L ANDERSON ASSISTANT SURGEON GENERAL 
CHIEF BUREAU STATE SERVICES.
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